Thursday's UK broker ratings

Updated every day, our UK broker ratings identify which FTSE- and AIM-listed companies are affected by a ratings change.

Listed below are details of selected companies that have undergone a ratings change today. Alternatively, download the pdf to see a full list of today's UK broker ratings.

UK broker ratings (13KB)


Pdfs require Adobe Reader, which is available free from  Adobe.

Upgrade

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Fresnillo Outperform 1200 31.1% RBC Capital Markets
National Grid Add 798 7.3% AlphaValue

 

Maintain

Company

Rating

Target price

Potential upside/Downside

Contributing broker

BG Group Outperform 1770 51.0% Sanford C. Bernstein & Co
British American Tobacco Overweight 4549 42.8% JPMorgan
Premier Oil Buy 450 36.3% Societe Generale

 

Downgrade

17.1%

Company

Rating

Target price

Potential upside/Downside

Contributing broker

British Sky Broadcasting Group Add 1029 17.1% AlphaValue
SAB Miller Neutral 3250 8.6% Credit Suisse
Standard Chartered Hold 1500 2.7% Numis Securities Ltd

 

Source: Bloomberg (3 October 2013)

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.